NCT00732316
- Conditions
- Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +30 more
- Locations
-
- Asan Medical Center - University of Ulsan College of Medicine Seoul, South Korea
Clinical trial condition
Immunoproliferative Disorders
Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.
9,965 public trials
2,022 recruiting studies
Immunoproliferative Disorders trial results
NCT00816283
- Conditions
- Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +21 more
- Locations
-
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- City of Hope Medical Group Pasadena, California, United States
NCT00796731
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- Sanofi-Aventis Investigational Site Number 250004 Créteil, France
- Sanofi-Aventis Investigational Site Number 250006 Lille, France
- Sanofi-Aventis Investigational Site Number 250001 Pierre-Bénite, France
- Sanofi-Aventis Investigational Site Number 250005 Rennes, France
Completed
Phase II Study of ONTAK in Previously Treated Patients With Low-grade Non-Hodgkin's Lymphoma (NHL)
NCT00051025
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Central Baptist Hospital Lexington, Kentucky, United States
- Hematology and Oncology Services Metairie, Louisiana, United States
NCT01639716
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
- Locations
-
- Ondokuz Mayis University Medical School Samsun, Atakum, Turkey (Türkiye)
NCT00476294
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- UT MD Anderson Cancer Center Houston, Texas, United States
NCT00439361
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin Lymphoma, +7 more
- Locations
-
- UT MD Anderson Cancer Center Houston, Texas, United States
NCT01077882
- Conditions
- Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +20 more
- Locations
-
- University Hospital Ghent Ghent, Belgium
Completed
Phase I Study of Perifosine + Lenalidomide and Dexamethasone for Patients With Multiple Myeloma
NCT00415064
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
- Locations
-
- Ann Arbor, Michigan, United States
Completed
Zoledronate With or Without Thalidomide in Treating Patients With Early Stage Multiple Myeloma
NCT00432458
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
- Locations
-
- Mayo Clinic Scottsdale Scottsdale, Arizona, United States
- Mayo Clinic - Jacksonville Jacksonville, Florida, United States
- Mayo Clinic Cancer Center Rochester, Minnesota, United States
- Memorial Sloan-Kettering Cancer Center New York, United States